← Open Payments lookup

ALYSSA FELVER: Open Payments

NPI 1336765437 · LEE, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,589 in 64 payments from 25 companies in 2025. Trend: 2023 $1,662 · 2024 $1,433 · 2025 $1,589

Food & beverage: $1,589
CompanyPaymentsAmount
Amgen Inc.7$228
Lilly USA, LLC6$197
Lundbeck LLC10$136
ABIOMED1$104
AstraZeneca Pharmaceuticals LP5$100
Calliditas Therapeutics US Inc.1$99
ABBVIE INC.4$92
Novo Nordisk Inc4$85
Sumitomo Pharma America, Inc.3$82
Indivior Inc.4$75

Products named: REPATHA, REXULTI, ZEPBOUND, TARPEYO, GEMTESA, SUBLOCADE, KISUNLA, EVENITY.

Industry payments across MA — which companies pay providers there.